Nexstim Oyj
OMXH:NXTMH
Nexstim Oyj
Operating Expenses
Nexstim Oyj
Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
Nexstim Oyj
OMXH:NXTMH
|
Operating Expenses
-€8.4m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
R
|
Revenio Group Oyj
OMXH:REG1V
|
Operating Expenses
-€24.8m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-20%
|
|
|
M
|
Modulight Oyj
OMXH:MODU
|
Operating Expenses
-€17.1m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
|
B
|
Bioretec Oy
OMXH:BRETEC
|
Operating Expenses
-€5.7m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
O
|
Optomed Oyj
OMXH:OPTOMED
|
Operating Expenses
-€15.6m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
B
|
Biohit Oyj
OMXH:BIOBV
|
Operating Expenses
-€6.3m
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
2%
|
|
Nexstim Oyj
Glance View
Nexstim Oyj engages in the provision of medical technology products. The company is headquartered in Helsinki, Etela-Suomen and currently employs 37 full-time employees. The company went IPO on 2014-11-14. The company is focused on improving rehabilitation for stroke patients through the use of noninvasive brain stimulation. Its offering comprises: a diagnostic tool for brain surgery planning, Navigated Brain Stimulation (NBS) System, which comprises navigated transcranial magnetic stimulation (nTMS) device for presurgical mapping (PSM) of the motor and speech cortices; and a device for stroke therapy called Navigated Brain Therapy (NBT) System, which focuses stimulation on targeted locations in the brain in order to enhance rehabilitation process. The NBT System targets upper limb motor disability and is under Phase III pivotal clinical trial study at rehabilitation sites in the United States. The Company’s systems are used in over 100 facilities in research, therapy and neurosurgical planning purposes. Nexstim Oyj has two subsidiaries: Nexstim Inc and Nexstim Germany GmbH.
See Also
What is Nexstim Oyj's Operating Expenses?
Operating Expenses
-8.4m
EUR
Based on the financial report for Jun 30, 2024, Nexstim Oyj's Operating Expenses amounts to -8.4m EUR.
What is Nexstim Oyj's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
2%
Over the last year, the Operating Expenses growth was -2%. The average annual Operating Expenses growth rates for Nexstim Oyj have been -6% over the past three years , 2% over the past five years .
You don't have any saved screeners yet